batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. J&J touts a Mariposa survival benefit 7 January 2025 I-Mab bets on a Bristol buy-in 6 January 2025 A fresh vote against integrins 3 January 2025 Happy new year, DLL3 2 January 2025 Tevimbra gets a different stomach cancer restriction 27 December 2024 Japan endorses the way of Datroway 27 December 2024 A new pivotal Nectin-4 player 23 December 2024 Third time lucky for Mesoblast 19 December 2024 Load More